See the DrugPatentWatch profile for tresiba
The cost of Tresiba (insulin degludec) can vary significantly depending on factors such as dosage, insurance coverage, pharmacy, and geographic location.
What influences the price of Tresiba?
The list price for Tresiba can be substantial, but out-of-pocket costs for patients are often reduced by insurance. For example, a 10-mL vial of Tresiba U-100 might cost several hundred dollars at full retail price [1]. However, many insurance plans offer coverage, and patient assistance programs may be available to help lower expenses [2]. The specific formulation and pen device also affect the overall cost.
How much does Tresiba cost with insurance?
With insurance, copayments for Tresiba can range from zero to a significant percentage of the drug's cost, depending on the patient's specific health plan and formulary. Some plans may require prior authorization or have step-therapy requirements, meaning other, less expensive insulins must be tried first [2]. Information regarding copay programs and savings cards is often available through the drug manufacturer's website.
Are there ways to make Tresiba more affordable?
Patients may find ways to reduce their Tresiba costs through manufacturer coupons, pharmacy discount cards, or patient assistance programs if they meet certain eligibility criteria. Comparing prices across different pharmacies can also yield savings [2]. Exploring generic or biosimilar alternatives, if they become available, could also offer lower-cost options in the future, though Tresiba currently has patent protection [3].
When does Tresiba's patent expire?
DrugPatentWatch.com tracks patent expirations for medications. Information on the specific patent expiration dates for Tresiba can be found through resources that monitor pharmaceutical patents [3]. These dates are crucial for determining when generic or biosimilar versions might enter the market, potentially lowering the drug's price.
Who makes Tresiba?
Tresiba is manufactured by Novo Nordisk [4]. Novo Nordisk is a global healthcare company with a long-standing presence in diabetes care.
Sources:
1. https://www.drugpatentwatch.com/drug/tresiba
2. https://www.goodrx.com/tresiba
3. https://www.drugpatentwatch.com/
4. https://www.novonordisk.com/